Home › Compare › SVPLF vs MRK

SVPLF vs MRK: Dividend Comparison 2026

SVPLF yields 142.86% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $935.00 in total portfolio value· pulled ahead in Year 10
10 years
SVPLF
SVPLF
● Live price
142.86%
Share price
$1.40
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$55.8K
Annual income
$39.57
Full SVPLF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SVPLF vs MRK

📍 MRK pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSVPLFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SVPLF + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SVPLF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SVPLF
Annual income on $10K today (after 15% tax)
$12,142.86/yr
After 10yr DRIP, annual income (after tax)
$33.63/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,294.78/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SVPLF + MRK for your $10,000?

SVPLF: 50%MRK: 50%
100% MRK50/50100% SVPLF
Portfolio after 10yr
$56.3K
Annual income
$4,918.86/yr
Blended yield
8.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SVPLF
No analyst data
Altman Z
3.2
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SVPLF buys
0
MRK buys
0
No recent congressional trades found for SVPLF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSVPLFMRK
Forward yield142.86% ✓2.76%
Annual dividend / share$2.00$3.32 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7% ✓
Portfolio after 10y$55.8K$56.8K ✓
Annual income after 10y$39.57$9,798.13 ✓
Total dividends collected$21.6K$28.9K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SVPLF vs MRK ($10,000, DRIP)

YearSVPLF PortfolioSVPLF Income/yrMRK PortfolioMRK Income/yrGap
1$17,843$7,142.86$11,206$366.19+$6.6K → SVPLF
2$25,047$5,955.56$12,650$502.35+$12.4K → SVPLF
3$30,707$3,906.68$14,407$694.19+$16.3K → SVPLF
4$35,095$2,238.07$16,585$967.82+$18.5K → SVPLF
5$38,747$1,195.26$19,342$1,363.89+$19.4K → SVPLF
6$42,076$616.65$22,913$1,947.19+$19.2K → SVPLF
7$45,334$312.91$27,662$2,823.89+$17.7K → SVPLF
8$48,665$157.54$34,159$4,173.35+$14.5K → SVPLF
9$52,151$79.03$43,337$6,308.80+$8.8K → SVPLF
10← crossover$55,841$39.57$56,776$9,798.13$935.00 → MRK

SVPLF vs MRK: Complete Analysis 2026

SVPLF — Stock

Kin and Carta plc provides technology, data, consultancy, and digital transformation services in the United Kingdom, the United States, and internationally. The company offers cloud and platforms, digital products, data and AI, managed, digital experiences, and strategy and innovation services. It serves agriculture, financial services, industrial, insurance, private equity, public, retail, and healthcare sectors. The company was formerly known as St Ives plc and changed its name to Kin and Carta plc in October 2018. Kin and Carta plc was incorporated in 1981 and is headquartered in London, the United Kingdom.

Full SVPLF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SVPLF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SVPLF vs SCHDSVPLF vs JEPISVPLF vs OSVPLF vs KOSVPLF vs MAINSVPLF vs JNJSVPLF vs ABBVSVPLF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.